Evidence map›Paper›PMID 37379126›Full record

ArticleAging2023

Comprehensive analysis reveals the involvement of hsa_circ_0037858/miR-5000-

Yuan Nianyong, Guowei Li

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. The Prognostic and Therapeutic Potential of Fragile X Mental Retardation 1 (International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yuan NianyongDepartment of Hepatobiliary and Pancreatic Surgery, The First People’s Hospital of Fuyang, Hangzhou 311400, China.
Guowei LiDepartment of Hepatobiliary and Pancreatic Surgery, The First People’s Hospital of Fuyang, Hangzhou 311400, China.
The First People's Hospital of Guiyang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear cell renal cell carcinoma (ccRCC) is a heterogenous tumor with high metastatic potential. Circular RNAs (circRNAs) play key roles in cancer initiation and progression. However, the knowledge of circRNA in ccRCC metastasis is still inadequate. In this study, a series of

Indexed as

Carcinoma, Renal CellKidney NeoplasmsMicroRNAsFragile X Messenger Ribonucleoprotein 1HumansPrognosisRNA, CircularFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1MicroRNAsMIRN5000 microRNA, humanRNA, Circularcircular RNA (circRNA)clear cell renal cell carcinoma (ccRCC)metastasismicroRNA (miRNA)

Identifiers

PMID37379126
PMCPMC10333075
OpenAlexW4382318205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.